Search
for
Sort by
Research 30 of 316
- Dermatological adverse events with taxane chemotherapy
- Permanent alopecia in patients with breast cancer after taxane chemotherapy and adjuvant hormonal therapy: Clinicopathologic findings in a cohort of 10 patients
- Persistent Alopecia in a Breast Cancer Patient Following Taxane Chemotherapy and Adjuvant Endocrine Therapy: Case Report and Review of Post-treatment Hair Loss in Oncology Patients with Breast Cancer
- 506 Taxane chemotherapy promotes aging of human hair follicles and their stem cells
- 803 Taxane chemotherapy induces epigenetic changes and premature senescence in human scalp hair follicles
- Safety, tolerability, and PK of topical calcitriol formulation for treatment of chemotherapy-induced alopecia (CIA) in patients receiving taxane-based regimen: Final results.
- Mechanism-Based Strategies for Prevention of Taxane-Induced Hair Follicle Damage in Cancer Chemotherapy
- Madarosis: a qualitative study to assess perceptions and experience of Australian patients with early breast cancer treated with taxane-based chemotherapy
- Chemotherapy-related adverse effects with anthracycline and taxane-containing regimens in patients with localized Breast cancer: a descriptive study
- Permanent Chemotherapy-Induced Alopecia in Patients with Breast Cancer: A 3-Year Prospective Cohort Study
- Annurca Apple Polyphenols Protect Murine Hair Follicles from Taxane Induced Dystrophy and Hijacks Polyunsaturated Fatty Acid Metabolism toward β-Oxidation
- Treatment of Chemotherapy Induced Alopecia
- Chemotherapy-Induced Alopecia in Breast Cancer Patients: Treatment-Specific Incidence and Risk of Persistent Hair Loss
- Chemotherapy-Induced Alopecia by Docetaxel: Prevalence, Treatment and Prevention
- A phase I safety study of topical calcitriol (BPM 31543) for the prevention of chemotherapy-induced alopecia (CIA).
- Expert consensus for prevention, diagnosis and management of persistent chemotherapy-induced alopecia.
- Permanent Alopecia in Breast Cancer Patients: Role of Taxanes and Endocrine Therapies
- Mucocutaneous side effects of antineoplastic chemotherapy
- Persistent chemotherapy-induced alopecia: updates in diagnosis and treatment persistent chemotherapy induced alopecia: an updated approach
- CDK4/6 inhibition mitigates stem cell damage in a novel model for taxane‐induced alopecia
- Low-Intensity Ultrasound as a Potential Intervention Strategy to Protect Human Scalp Hair Follicles from Taxane-Induced Toxicity
- Chemotherapy-induced alopecia: A novel observation
- Chemotherapy and the Skin: Understanding Dermatologic Side Effects
- Alopecia due to chemotherapeutics, hedgehog inhibitors, targeted antibody therapies and immune checkpoint inhibitors
- 1400 Low-intensity ultrasound protects human scalp hair follicles from taxane-induced toxicity
- Management of Chemotherapy-Induced Alopecia With Scalp Cooling
- Hair safe study: Effects of scalp cooling on hair preservation and hair regrowth in breast cancer patients receiving chemotherapy - A prospective interventional study
- Topical calcitriol (BPM31543) for the prevention of chemotherapy-induced alopecia (CIA): Efficacy findings from a phase I safety study.
- Abstract P3-09-15: Permanent chemotherapy induced alopecia in early breast cancer patients after (neo)adjuvant chemotherapy: Long term follow up
- Objective quantification of chemotherapy-induced madarosis: a pilot study of an automated computer vision pipeline for eyebrow density assessment